title: Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT.
authors: A
authors: A
authors: Honda
authors: K
authors: K
authors: Kakihana
authors: J
authors: J
authors: Aoki
authors: T
authors: T
authors: Kobayashi
authors: N
authors: N
authors: Doki
authors: H
authors: H
authors: Sakamaki
authors: K
authors: K
authors: Ohashi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000379:methods*; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D016559:Tacrolimus / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus; D008727:Methotrexate